Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Hampshire Health Report.
Press releases published on May 16, 2025
Innovations in High Blood Pressure Intervention Benefit Patients with Resistant Hypertension
GlobeNewswire
·
May 16, 2025
Palo Alto, CA, May 16, 2025 (GLOBE NEWSWIRE) -- May 17, 2025, is World Hypertension Day, a day dedicated to raising awareness about high blood pressure, also known as the “silent killer” because many people do not know they have it and, over time, it can …
Mitolyn Reviews 2025 (Exposed Fake or Real): An Innovative Way to Lose Weight and a Healthy Mitochondria
GlobeNewswire
·
May 16, 2025
New York City, NY, May 16, 2025 (GLOBE NEWSWIRE) -- In This Article, You'll Discover: The main theme of Mitolyn as a popular weight loss supplement in the US is enhancing mitochondria and achieving continual weight loss. Official MITOLYN Website What is …
Medicines for Poland: Europa steht vor einer kritischen Entscheidung über Arzneimittel und Marktreformen
GlobeNewswire
·
May 16, 2025
Warschau, Polen, May 16, 2025 (GLOBE NEWSWIRE) -- Die Mitgliedstaaten stehen kurz vor dem Abschluss der Diskussionen über die EU-Arzneimittelreform, mit der erschwingliche Medikamente sichergestellt und die Produktion in Europa gefördert werden sollen. …
Medicines for Poland : l’Europe fait face à un dilemme majeur sur la question des médicaments et de la réforme du marché
GlobeNewswire
·
May 16, 2025
VARSOVIE, Pologne, 16 mai 2025 (GLOBE NEWSWIRE) -- Les États membres s’apprêtent à conclure les discussions sur la réforme pharmaceutique de l’UE afin de garantir des médicaments abordables et de soutenir la production de l’UE au sein de l’Europe. Cela …
Medicines for Poland : l'Europe face à un choix crucial en matière de médicaments et de réforme du marché
GlobeNewswire
·
May 16, 2025
VARSOVIE, Pologne, 16 mai 2025 (GLOBE NEWSWIRE) -- Les États membres approchent de la fin des discussions sur la réforme pharmaceutique de l'UE visant à garantir des médicaments abordables et à soutenir la fabrication de médicaments de l'UE en Europe. Cela …
CircO2 Review - Best Nitric Oxide Supplement for Men and Women: Boost Energy, Heart Health and Circulation - Advanced Bionutritionals
GlobeNewswire
·
May 16, 2025
Norcross, GA, May 16, 2025 (GLOBE NEWSWIRE) -- Proper nutrition serves as the cornerstone of a vibrant and productive life. The food we consume directly impacts our physical, mental, and emotional well-being. A balanced diet, rich in essential nutrients, …
Basel Medical Group Ltd Kicks Off US$ 1.0 Billion Bitcoin (BTC) Acquisition Strategy Move
GlobeNewswire
·
May 16, 2025
Singapore, May 16, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL or the “Company”), today announced that it has begun exclusive negotiations for a US$1 billion BTC acquisition that will diversify its treasury reserves to a very large …
GRI Bio to Present at A.G.P.'s Annual Healthcare Company Showcase
GlobeNewswire
·
May 16, 2025
Live webcast fireside chat with Marc Hertz, PhD, Chief Executive Officer on Wednesday, May 21st at 2:40 PM ET LA JOLLA, CA, May 16, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an …
SRx Health Solutions Further Diversifies Treasury Strategy with Purchase of Ethereum
GlobeNewswire
·
May 16, 2025
TAMPA, Fla., May 16, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”), a leading global health and wellness company, today announced further diversifying its treasury strategy with the purchase of Ethereum (ETH). …
Psychemedics Named “Most Innovative Drug Testing Company of the Year”
GlobeNewswire
·
May 16, 2025
DALLAS, May 16, 2025 (GLOBE NEWSWIRE) -- Psychemedics Corporation, the world’s leading provider of hair drug testing, is proud to announce it has been named “Most Innovative Drug Testing Company of the Year” by Acquisition International Magazine as part of …
Scilex Holding Company Presented Post-Hoc Analysis of the C.L.E.A.R. Trial on Clinical Meaningfulness of Safety and Efficacy of SP-102 for the Treatment of Lumbosacral Radicular Pain (LRP) at the 27th Annual Meeting of American Society of…
GlobeNewswire
·
May 16, 2025
PALO ALTO, Calif., May 16, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the …
BON Announces The Launch Of Its Postbiotic Hypoglycemic Patented Ingredient Product Series And Its Cooperation Agreement
GlobeNewswire
·
May 16, 2025
XI’AN, China, May 16, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, announced an exclusive cooperation agreement with …
Medicines for Poland: Europe Faces a Critical Choice on Medicines and Market Reform
GlobeNewswire
·
May 16, 2025
WARSAW, Poland, May 16, 2025 (GLOBE NEWSWIRE) -- Member States are nearing the end of discussions on EU pharmaceutical reform to ensure affordable medicines and support EU manufacturing in Europe. This will enhance the Union’s strategic resilience and …
Orthopedic Devices Market worth US$68.51 billion by 2030 with 4.8% CAGR | MarketsandMarkets™.
GlobeNewswire
·
May 16, 2025
Delray Beach, FL, May 16, 2025 (GLOBE NEWSWIRE) -- The global orthopedic devices market , valued at US$49.63 billion in 2023, is forecasted to grow at a robust CAGR of 4.8%, reaching US$51.61 billion in 2024 and an impressive US$68.51 billion by 2030. The …
FibroBiologics Presents at the Society for Investigative Dermatology Annual Meeting
GlobeNewswire
·
May 16, 2025
HOUSTON, May 16, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 240+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic …
Conduit Pharmaceuticals Inc. Announces Reverse Stock Split
GlobeNewswire
·
May 16, 2025
NAPLES, Fla. and CAMBRIDGE, United Kingdom, May 16, 2025 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) (“Conduit” or the “Company”), a dynamic, multi-asset clinical stage, life science company delivering an efficient model for compound …
Mainz Biomed Announces Interim Read Out For Its eAArly DETECT 2 Clinical Study
GlobeNewswire
·
May 16, 2025
Company intends to provide an interim read out by the end of summer 2025 Top-line results anticipated in Q4 2025; study on track to support U.S. pivotal trial initiation in 2026 BERKELEY, Calif. and MAINZ, Germany, May 16, 2025 (GLOBE NEWSWIRE) -- Mainz …
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 16, 2025
SOUTH SAN FRANCISCO, Calif., May 16, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and …
Vivex Biologics, Inc. Executive Chair Nominated for Ernst & Young LLP Entrepreneur of the Year® 2025 Florida Award
GlobeNewswire
·
May 16, 2025
MIAMI, May 16, 2025 (GLOBE NEWSWIRE) -- Vivex Biologics, Inc., a leader in developing and delivering innovative allografts, today announced the company’s Executive Chairman, John A. McCallum, has been selected as a finalist in the prestigious Ernst …
Replimune Announces Dates for Fiscal Fourth Quarter and Year End 2025 Financial Results and Upcoming Investor Day
GlobeNewswire
·
May 16, 2025
WOBURN, Mass., May 16, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that it will host a conference call on Thursday, May …